Skip to main content
. Author manuscript; available in PMC: 2024 Mar 22.
Published in final edited form as: Cell Oncol (Dordr). 2022 Jan 7;45(1):19–40. doi: 10.1007/s13402-021-00640-x

Table 2.

Cell Type Assignments Summary

Cell Type Total % % Control % D1 %D2

Brain (Neuron, CNS, Cerebral Cortex 11.97 4.5 3.2 4.23

Epithelial 0.3 0 0.14 0.14

Embryonic Stem Cell (ESC) 72 24.4 21.78 26.16

Hematopoietic Stem Cells
1(T1-LT) 0.43 0.43 0.14 0
ZYGOT 0.73 0.14 0.14 0.43

Spleen and Lymph Nodes 4.67 1.60 1.46 1.60

Endothelial 0.3 0 0.14 0.14

Thymus 0.58 0.14 0 0.43

2HSPC 1.6 0.29 0.58 0.73

Progenitor 4 1.16 0.43 2.48

Cancer Lymphocytic 1.30 0.4 0.14 0.73
1

T1-HSC: CD31+VE-cadherin+CD45CD41lowc-Kit+ in E11 aorta–gonad– mesonephros Hematopoietic Stem Cells; LT-HSCs: Lin, c-Kit+, Sca1+, CD34, Flk2 Hematopoietic Stem Cells; T1-HSC: CD31+VE-cadherin+CD45CD41lowc- Kit+ in E11 aorta–gonad–mesonephros Hematopoietic Stem Cells

2

HSPC: Hematopoietic Stem Cells and Progenitor Cells